Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSteppe Cement Regulatory News (STCM)

Share Price Information for Steppe Cement (STCM)

Share Price is delayed by 15 minutes
Get Live Data
20.00    0.00 (0.00%)
Bid:
19.00
Ask:
21.00
Spread: 2.00 (10.526%)
Market Cap: £43.80m
STCM Live PriceLast checked at - London Stock Exchange

Intraday Steppe Cement Share Chart

Director Appointment

19 Dec 2008 07:00

RNS Number : 4486K
Steppe Cement Limited
19 December 2008
 



Steppe Cement Limited

19 December 2008

Appointment of Non-Executive Chairman

Steppe Cement Limited ("Steppe" or the "Company") is pleased to confirm the appointment of Mr Malcolm Ronald Brown to its Board of Directors with immediate effect as a non-executive chairman. 

Mr Brown, 62 years of age, is a UK national with a background as an analyst and corporate finance adviser. He has significant experience with the European building materials sector and has been involved in a number of cement related transactions. 

Mr Brown worked with HSBC Investment Bank and its predecessor James Capel for 34 years as a director, senior analyst and adviser until his retirement in 2006The research output, supported by a strong specialist sales team, enabled James Capel and subsequent to its purchase, by HSBC, to establish a leading position in the building material and construction sector in both the primary and the secondary market. This was reflected in the external poll ratings and the expanded number of corporate brokerships. 

Some of the mandates in which Mr Brown was actively involved included the privatisation of the cement industry in Serbia and those in Algeria. In the former case following the cessation of hostilities it was decided in 2001 that the three plants Beocin, Novi Popovac and Kosjeric should be sold and following a successful competitive auction, which was fast-tracked these were acquired by Lafarge, Holcim and Titan respectively. In Algeria HSBC won the mandate to advise the government on the sale of its cement assets and it was decided to prepare three out of the twelve plants for auction. Regrettably, although this had proceeded a long way, even to soliciting offers from international cement groups, the government withdrew at the eleventh hour in the face of strong union opposition.  Whilst at HSBC Mr Brown was also engaged to find acquisitions on the Indian sub continent for Holcim (Switzerland), Cimpor (Portugal) and Votorantim (Brazil). He has also worked with Vicat and Ciments Francais on opportunities in Egypt.

Mr Brown is currently the managing director of a small consultancy business, Carbery Cement Consultants, which provides strategic advice to mid cap, family-controlled businesses in the cement industry. 

Mr Brown was a non-executive director of UK building products supplier Panablok Holdings Ltd ("Panablok") between January and September 2007. Panablok entered into administration on 25th October 2007 with the appointment of Clarke Bell Limited. Mr Brown has not been a director of any other company or a partner in any other business during the past five years.

Aside from the above, Mr Brown has not been involved with any unspent convictions in relation to indictable offences, bankruptcy, voluntary arrangements with creditors, receiverships, compulsory liquidations, creditors' voluntary liquidations, administrations or other matters which require disclosure pursuant to paragraph (g) of Schedule 2 of the AIM Rules. 

Mr Brown currently does not hold any interests in the issued capital of Steppe. 

There are no other matters in relation to Mr Malcolm Brown that require disclosure under the AIM Rules. 

The Company's Nominated Adviser is RFC Corporate Finance Ltd.

Contact: Stephen Allen or Trinity McIntyre, ph: +61 8 9480 2500.

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOADGMMZGLNGRZG
Date   Source Headline
27th May 20267:00 amRNSNotice of AGM
27th May 20267:00 amRNSAnnual Financial Report
10th Apr 20267:00 amRNSTrading Update for the Quarter ended 31 March 2026
19th Jan 20268:03 amRNSInvestor Presentation via Investor Meet Company
15th Jan 20263:02 pmRNSReplacement - Trading Update
15th Jan 202610:45 amRNSTrading Update, Board Changes and Investment Plan
29th Dec 20257:00 amRNSCapital Repayment Payment Date
29th Dec 20257:00 amRNSCapital Repayment Payment Date
9th Dec 202510:30 amRNSCapital Repayment Record Date
5th Dec 20259:17 amRNSResult of EGM
14th Nov 20257:00 amRNSProposed Reduction & Repayment of Capital and EGM
17th Oct 20257:00 amRNSTrading Update for Q3 2025
15th Sep 20257:00 amRNSHalf-year Report
25th Jul 202511:07 amRNSResult of AGM
21st Jul 20251:34 pmRNSAGM – Submission of Shareholder Questions
7th Jul 20258:00 amRNSTrading Update
26th Jun 20257:55 amRNSNotice of AGM
26th Jun 20257:54 amRNSAnnual Financial Report
8th Apr 20258:29 amRNSTrading update for the quarter ended 31 March 2025
14th Jan 20257:00 amRNSYear End Trading Update
2nd Jan 202510:00 amRNSCapital Repayment Payment
12th Dec 20247:00 amRNSCapital Repayment Record Date
6th Dec 20248:39 amRNSResult of EGM
15th Nov 20247:00 amRNSProposed Reduction & Repayment of Capital and EGM
14th Oct 20247:00 amRNSTrading Update for Q3 2024
4th Oct 20249:15 amRNSHolding(s) in Company
20th Sep 20247:00 amRNSHalf-year Report
6th Aug 20248:21 amRNSDirector's Dealing
2nd Aug 20249:44 amRNSDirector's Dealing
12th Jul 202410:08 amRNSResult of AGM and Market Update for H1 2024
4th Jul 20247:00 amRNSAGM - Submission of Shareholder Questions
19th Jun 20247:00 amRNSNotice of AGM
19th Jun 20247:00 amRNSAnnual Financial Report
23rd May 20247:00 amRNSCapital Repayment Record Date
26th Apr 20249:53 amRNSResult of EGM
9th Apr 20249:42 amRNSDirector's Dealing
5th Apr 20247:01 amRNSProposed Return of Cash to Shareholders and EGM
5th Apr 20247:00 amRNSTrading update for the quarter ended 31 March 2024
12th Jan 202410:15 amRNSYear End Trading Update
13th Dec 20239:15 amRNSUpdate re intention to pay a dividend
28th Nov 202311:44 amRNSDirector's Dealing
23rd Nov 20237:41 amRNSDirector's Dealing
11th Oct 20239:44 amRNSMarket Update for the Third Quarter September 2023
20th Sep 202310:19 amRNSDirector's Dealing
19th Sep 20239:00 amRNSHalf-year Report
13th Jul 20237:00 amRNSResult of AGM
12th Jul 20237:00 amRNSMarket Update - First half of 2023
4th Jul 20237:00 amRNSNotice of AGM and Submissions of Questions
9th Jun 20237:00 amRNSNotice of AGM
9th Jun 20237:00 amRNSAnnual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.